- Home
- MNDO vs ADVB Comparison
MNDO vs ADVB Comparison
Compare MNDO & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDO
- ADVB
- Stock Information
- Founded
- MNDO 1995
- ADVB 2014
- Country
- MNDO Israel
- ADVB United States
- Employees
- MNDO N/A
- ADVB N/A
- Industry
- MNDO EDP Services
- ADVB Medical Specialities
- Sector
- MNDO Technology
- ADVB Health Care
- Exchange
- MNDO Nasdaq
- ADVB Nasdaq
- Market Cap
- MNDO 34.2M
- ADVB 36.1M
- IPO Year
- MNDO 2000
- ADVB 2025
- Fundamental
- Price
- MNDO $1.48
- ADVB $0.94
- Analyst Decision
- MNDO
- ADVB
- Analyst Count
- MNDO 0
- ADVB 0
- Target Price
- MNDO N/A
- ADVB N/A
- AVG Volume (30 Days)
- MNDO 33.2K
- ADVB 72.3K
- Earning Date
- MNDO 05-06-2025
- ADVB 08-03-2025
- Dividend Yield
- MNDO 14.77%
- ADVB N/A
- EPS Growth
- MNDO N/A
- ADVB N/A
- EPS
- MNDO 0.17
- ADVB N/A
- Revenue
- MNDO $20,677,000.00
- ADVB N/A
- Revenue This Year
- MNDO N/A
- ADVB N/A
- Revenue Next Year
- MNDO N/A
- ADVB N/A
- P/E Ratio
- MNDO $8.76
- ADVB N/A
- Revenue Growth
- MNDO N/A
- ADVB N/A
- 52 Week Low
- MNDO $1.34
- ADVB $0.86
- 52 Week High
- MNDO $2.13
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- MNDO 43.62
- ADVB N/A
- Support Level
- MNDO $1.45
- ADVB N/A
- Resistance Level
- MNDO $1.50
- ADVB N/A
- Average True Range (ATR)
- MNDO 0.04
- ADVB 0.00
- MACD
- MNDO 0.01
- ADVB 0.00
- Stochastic Oscillator
- MNDO 80.00
- ADVB 0.00
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.